1 Min Read
Jan 18 (Reuters) - Global Blood Therapeutics Inc :
* Global blood therapeutics announces enrollment of first patient in phase 3 hope study in sickle cell disease Source text for Eikon: Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2017 Reuters. All Rights Reserved.